Zpráva o průběhu klinického hodnocení MSC-EB 12. října 2022 ‒ 11. října 2023
| Title in English | MSC-EB Clinical Trial Progress Report October 12, 2022 - October 11, 2023 |
|---|---|
| Authors | |
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | MSC-EB |
| Description | The annual report gives the overview of the conduct of the clinical trial „Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells in Patients with Epidermolysis Bullosa: Clinical Trial Phase I/II“. The primary aim of the clinical trial is to study the safety of innovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor. |
| Related projects: |